MD HB289 | 2012 | Regular Session

Status

Sponsorship: Partisan Bill (Democrat 1)
Status: Introduced on January 27 2012 - 25% progression, died in chamber
Action: 2012-03-06 - Unfavorable Report by Health and Government Operations Withdrawn
Text: Latest bill text (Introduced) [PDF]

Summary

Altering the name of the Stem Cell Research Commission to be the Stem Cell and Biotechnologies Commercialization Commission; requiring the Commission to establish procedures and guidelines regarding research supporting a qualified technology; altering the name of the Maryland Stem Cell Research Fund to be the Maryland Stem Cell and Biotechnologies Commercialization Fund; altering the purpose of the Fund so as to support innovative biotechnology research and development that has the potential to create job growth; etc.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Economic Development - Maryland Stem Cell Research Act - Revisions

Sponsors


History

DateChamberAction
2012-03-06 Unfavorable Report by Health and Government Operations Withdrawn
2012-02-01 Hearing 2/7 at 1:30 p.m. (Health and Government Operations)
2012-01-27 First Reading Health and Government Operations & Economic Matters

Subjects


Maryland State Sources


feedback